Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES    
Net income $ 4,248 $ 2,332
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for doubtful accounts 212 39
Depreciation 6,045 6,166
Loss on disposal of and reserve adjustments for medical equipment 502 380
Gain on sale of medical equipment (96) (1,723)
Amortization of intangible assets 384 495
Amortization of deferred debt issuance costs 42 39
Stock-based compensation 2,475 1,769
Deferred income taxes 1,040 1,363
Changes in assets - (increase)/decrease:    
Accounts receivable (5,689) (2,089)
Inventories 593 863
Other current assets (43) 24
Other assets 637 1,106
Changes in liabilities - (decrease)/increase:    
Accounts payable and other liabilities (2,603) (1,975)
NET CASH PROVIDED BY OPERATING ACTIVITIES 7,747 8,789
INVESTING ACTIVITIES    
Acquisition of business 0 (1,412)
Purchase of medical equipment (6,543) (4,314)
Purchase of property and equipment (248) (348)
Proceeds from sale of medical equipment, property and equipment 1,008 1,728
NET CASH USED IN INVESTING ACTIVITIES (5,783) (4,346)
FINANCING ACTIVITIES    
Principal payments on long-term debt (12,890) (30,261)
Cash proceeds from long-term debt 13,648 32,717
Debt issuance costs 0 (12)
Common stock repurchased as part of share repurchase program (4,358) (6,395)
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (775) (458)
Cash proceeds from exercise of options and ESPP 189 159
NET CASH USED IN FINANCING ACTIVITIES (4,186) (4,250)
Net change in cash and cash equivalents (2,222) 193
Cash and cash equivalents, beginning of period 3,186 527
Cash and cash equivalents, end of period $ 964 $ 720